October 06, 2022 13:00 ET | Source: DelveInsight Business Research LLP DelveInsight Business Research LLP

New York, USA, Oct. 06, 2022 (GLOBE NEWSWIRE) -- The Global Sepsis Diagnostics Market to Register Growth at a CAGR of 9.60% by 2027 | DelveInsight

The sepsis diagnostics market is expanding due to factors such as the rising prevalence of the COVID-19 pandemic, an increase in the geriatric population, an increase in the prevalence of bacterial infections such as tuberculosis, and an increase in regulatory approvals for technologically advanced sepsis diagnostics products. As a result, the sepsis diagnostics market is expected to grow at a significant CAGR from 2022 to 2027.

DelveInsight’s Sepsis Diagnostics Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies’ market shares, challenges, sepsis diagnostics market drivers, barriers, and trends, and key sepsis diagnostics companies in the market. 

Key Takeaways from the Sepsis Diagnostics Market Report

To read more about the latest highlights related to the sepsis diagnostics market, get a snapshot of the key highlights entailed in the Global Sepsis Diagnostics Market Report 

Sepsis is a potentially fatal condition that occurs when the body's response to an infection causes tissue damage. When the body's infection-fighting processes activate, organs function poorly and abnormally. Sepsis can lead to septic shock. This is a significant drop in blood pressure that can result in severe organ damage and death. Sepsis diagnostics include instruments, lab tests, various technologies, and others that are used to diagnose sepsis by examining the patient for signs of infection or organ damage.

Learn more about sepsis diagnostics procedures @Diagnositc Tools for Sepsis

North America is expected to dominate the global sepsis diagnostics market in 2021 and will continue to do so throughout the forecast period of 2022–2027. Factors such as the rising prevalence of bacterial infections such as tuberculosis and an increase in regulatory approvals for technologically advanced sepsis diagnostics products are expected to drive demand for sepsis diagnostics in the North American sepsis diagnostics market.

Furthermore, the increased regulatory approvals for technologically advanced sepsis diagnostics products may boost the region's overall sepsis diagnostics market. Noninvasix, for example, announced in February 2022 that its LIVOxTM Central Venous Oxygenation Monitor had received Breakthrough Device Designation from the United States Food and Drug Administration (FDA) for non-invasive, real-time, continuous, or spot monitoring of central venous oxygen saturation (ScvO2) in adults at risk of septic shock in the United States.

To know more about why North America is leading the market growth in the sepsis diagnostics market, get a snapshot of the Sepsis Diagnostics Market Trends

The rising prevalence of COVID-19 is one of the primary drivers of the sepsis diagnostics market. Furthermore, the growing geriatric population is another major contributor to the rise in the sepsis diagnostics market. However, the high cost of sepsis treatment and a lack of awareness and knowledge about sepsis may impede the growth of the global sepsis diagnostics market.

Additionally, the COVID-19 outbreak has had a marginally positive impact on the sepsis diagnostics market. SARS-CoV-2 causes sepsis, according to the Global Sepsis Alliance. A recent study found that viral sepsis is the most common complication in COVID-19 patients and is associated with increased mortality. Although COVID-19 affects the patient's respiratory system, with most patients requiring hospitalization for pneumonia of varying severity, almost all other organ systems can be impacted. This fits with a combination of sepsis and direct viral invasion. Thus, the increase in COVID-19 pandemic cases increased demand for sepsis diagnostics, and an increase in COVID-19 cases is expected to increase demand for tools, reagents, and test kits for sepsis detection, resulting in an increase in the sepsis diagnostics market.

Get a sneak peek at the sepsis diagnostics market dynamics @Sepsis Diagnostics Market Dynamics Analysis

Which MedTech key players in the sepsis diagnostics market are set to emerge as the trendsetter explore @Sepsis Diagnostics Companies 

Interested in knowing the sepsis diagnostics market by 2027? Click to get a snapshot of the Sepsis Diagnostics Market Research

Sepsis Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key sepsis companies, including Inotrem, Par Pharmaceutical, Enlivex Therapeutics, among others.

Sepsis Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical, and forecasted sepsis epidemiology in the 7MM.

Sepsis Pipeline Insight – 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key sepsis companies, including Inotrem, Par Pharmaceutical, Enlivex Therapeutics, Sanofi, among others.

Community-acquired Bacterial Pneumonia Pipeline Insight – 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key community-acquired bacterial pneumonia companies, including as Allergan, Eagle Pharmaceutical Inc, Combioxin SA, Takeda, among others.

Community-acquired Pneumonia Pipeline Insight – 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key community-acquired pneumonia companies, including Nabriva Therapeutics, Melinta Therapeutics, Wakunaga Pharmaceutical, among others.

Pneumonia Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key pneumonia companies, including Pfizer, Affinivax, Merck Sharp &Dohme Corp., Vaxcyte, among others.

Goitre Market |  Thymus Cancer Market | US Healthcare Outlook Report | Venous Stenosis Market | Negative Pressure Wound Therapy Systems Market | Global Kinase Inhibitor in Autoimmune Diseases Market | Metrorrhagia Market | Dysfunctional Uterine Bleeding Market | Hypereosinophilic Syndrome Market | Age-related Vision Dysfunction Market | Dental Lasers Market | CRISPR Therapies Pipeline Insight | Cell And Gene Therapy For Multiple Myeloma Market | Drug Hypersensitivity Market | Dysthymia Market | Persistent Depressive Disorder Market | Cancer Vaccines Market | Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Market | Substance use disorder Market | Idiopathic Thrombocytopenic Purpura Market | Spinal Fusion Devices Market | Atherectomy Devices Market | Prosthetic Heart Valve Market | Cardiac Monitoring System Market | Chemotherapy-induced nausea and vomiting (CINV) Market | Diabetes Market | Ocular Melanoma Market | Breast Pumps Market | Stereotactic Surgery Devices Market  Atopic Dermatitis Market | Concussions Market | Osteoporosis Market | Myelofibrosis (MF) Market | Cancer Cachexia (CC) Market

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.